Literature DB >> 17786929

Integrated activation of MAP3Ks balances cell fate in response to stress.

Ann M Winter-Vann1, Gary L Johnson.   

Abstract

In vivo, tissues and organs are exposed to numerous stressors that require cells to respond appropriately for viability and homeostasis. Cells respond to these stressors, which range from UV irradiation, heat shock, chemicals, and changes in osmolality, to oxidative stress and inflammatory cytokines, by activating pathways that protect cells from damage. If the stress is too great, cells commit to undergo apoptosis. Such cell fate decisions involve the stress-mediated activation of mitogen-activated protein kinase (MAPK) networks, ultimately under the control of MAPK kinase kinases, or MAP3Ks. It is the MAP3Ks that coordinate the localization, duration and magnitude of MAPK activation in response to cell stress. A single stressor may activate several MAP3Ks, each of which impacts the balance between survival and apoptotic signaling. In this prospect article, we review the specific MAP3Ks that integrate the physiological response to cell stressors. The interrelationships among different stressors are discussed, with an emphasis on how the balance of signaling through MAP3Ks controls the MAPK response to determine cell fate. (c) 2007 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2007        PMID: 17786929     DOI: 10.1002/jcb.21522

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  33 in total

1.  Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.

Authors:  Yongqing Li; Hasan B Alam
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.

Authors:  Shu-Chen Wei; Ian M Rosenberg; Zhifang Cao; Alan S Huett; Ramnik J Xavier; Daniel K Podolsky
Journal:  Inflamm Bowel Dis       Date:  2012-01-23       Impact factor: 5.325

3.  Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.

Authors:  Ashley R Kochanek; Eugene Y Fukudome; Yongqing Li; Eleanor J Smith; Baoling Liu; George C Velmahos; Marc deMoya; David King; Hasan B Alam
Journal:  J Surg Res       Date:  2011-07-05       Impact factor: 2.192

Review 4.  Visualization of the spatial and temporal dynamics of MAPK signaling using fluorescence imaging techniques.

Authors:  Taichiro Tomida
Journal:  J Physiol Sci       Date:  2014-08-22       Impact factor: 2.781

5.  Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.

Authors:  Maya Breitman; Seunghyi Kook; Luis E Gimenez; Britney N Lizama; Maria C Palazzo; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

6.  Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination.

Authors:  Debora Bogani; Pam Siggers; Rachel Brixey; Nick Warr; Sarah Beddow; Jessica Edwards; Debbie Williams; Dagmar Wilhelm; Peter Koopman; Richard A Flavell; Hongbo Chi; Harry Ostrer; Sara Wells; Michael Cheeseman; Andy Greenfield
Journal:  PLoS Biol       Date:  2009-09-15       Impact factor: 8.029

7.  p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice.

Authors:  Luca Carta; Silvia Smaldone; Lior Zilberberg; David Loch; Harry C Dietz; Daniel B Rifkin; Francesco Ramirez
Journal:  J Biol Chem       Date:  2008-12-24       Impact factor: 5.157

8.  Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L.

Authors:  Ping Zhang; Jeffrey O Langland; Bertram L Jacobs; Charles E Samuel
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

9.  Protein targets of reactive metabolites of thiobenzamide in rat liver in vivo.

Authors:  Keisuke Ikehata; Tatyana G Duzhak; Nadezhda A Galeva; Tao Ji; Yakov M Koen; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2008-06-12       Impact factor: 3.739

10.  Protein targets of thioacetamide metabolites in rat hepatocytes.

Authors:  Yakov M Koen; Diganta Sarma; Heather Hajovsky; Nadezhda A Galeva; Todd D Williams; Jeffrey L Staudinger; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2013-03-20       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.